Standout Papers

Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor 2010 2026 2015 2020 593
  1. Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor (2010)
    James E. Butrynski, David R. D’Adamo et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 17 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Hallmarks of aging: An expanding universe
2023 Standout
cGAS–STING drives ageing-related inflammation and neurodegeneration
2023 StandoutNature
1 intermediate paper

Works of James E. Butrynski being referenced

Clinical presentation and management of mTOR inhibitor-associated stomatitis
2011

Author Peers

Author Last Decade Papers Cites
James E. Butrynski 1990 1165 615 720 52 3.2k
Adrián Mariño‐Enríquez 2174 839 414 1105 92 3.5k
Tiziana Negri 1815 963 513 973 67 3.0k
David R. D’Adamo 3144 2565 496 957 65 4.7k
Isabelle Hostein 2389 1022 585 830 61 3.6k
Kirsten Sundby Hall 2325 967 703 677 103 3.3k
Philippe Terrier 2135 935 393 1215 60 3.3k
Yutaka Daimaru 1229 586 504 779 43 2.4k
Dominique Ranchère‐Vince 2906 1374 373 1178 87 3.8k
Leona A. Doyle 1996 1115 215 1444 62 3.3k
W. Ruka 1359 1429 575 311 57 2.5k

All Works

Loading papers...

Rankless by CCL
2026